search Search
search Search

EASD 2025 in Vienna

    • Vienna, September 16, 2025 – At EASD 2025, during the live symposium “Moving with CamAPS FX in T1D: Real-Time Exercise, Real-Life Insights”, Prof. Othmar Moser led a compelling live display. Three recreational athletes with type 1 diabetes using myLoop powered by CamAPS FX – Markus, Pia, and Leo – performed different types of exercise. This dynamic demonstration combined physiology, technology, and lived experience in real time, bringing to life the recommendations from the recent EASD/ISPAD position paper on AID and exercise.1

    4 Key Physiological Insights

    1. Exercise type matters: Endurance training typically lowers glucose, while high-intensity interval training (HIIT) and resistance training can stabilize or even raise levels due to catecholamine effects.

    2. Insulin on board drives hypoglycemia risk: Not exercise itself, but residual insulin action, highlights the importance of adaptive insulin delivery.

    3. Time of day influences insulin needs: Morning activity often requires more insulin without AID, but CamAPS FX adapts automatically.

    4. Stable pre-exercise glucose is essential: Keeping levels steady in the two hours before training helps prevent early hypoglycemia.

    Watch the full recording on-demand for expert perspectives on optimizing exercise management in AID therapy.

    4 Key Recommendations Demonstrated

    1. Activate "Ease-off" about 2 hours before planned exercise to reduce insulin delivery and avoid glucose drops.

    2. Use "Boost" only when glucose is rising, and only for experienced users.

    3. Adjust carbohydrate intake to glucose trends:

      • Fast drop: 12–20 g

      • Slower decline: 6–12 g

      • Always log carbs as “hypoglycemia treatment” for correct insulin adjustments.

    4. After exercise, some athletes preferred a temporary glucose target of 6.7 mmol/L to reduce risk of late hypoglycemia.

    Athletes’ Experiences with the system

    • Markus, endurance runner: Even during a week of running six hours daily, he did not experience clinically relevant hypoglycemia – underscoring the robustness of the system in prolonged endurance conditions.

    • Pia, HIIT cyclist: Highlighted the comfort and safety of the system, particularly overnight, with fewer nocturnal corrections thanks to stable glucose levels.

    • Leo, strength athlete: Found CamAPS FX easier to handle than pens or conventional pumps, with generally better glucose outcomes during resistance training.

    Together, the athletes agreed that the system provided greater confidence, fewer interruptions, and better quality of life – especially in the hours following exercise, when glucose levels can otherwise be unpredictable.

    Implications for Clinical Practice

    This demonstration highlights a central message: exercise does not have to mean loss of glucose control. With the adaptive features of CamAPS FX and appropriate preparation, people with type 1 diabetes can train more safely, with higher confidence and improved quality of life.

    Want to learn more?

    Explore our dedicated brochures for practical exercise management tips and watch (or rewatch) the full symposium video for exclusive expert insights.

    • 1 / 0